The status of cannabis in the UN drug conventions is controversial. It is now scheduled among the most dangerous substances. How and why did cannabis in the conventions? Does it belong there? What are the options to review the status of cannabis according to current scientific data? Is making cannabis subject to a control regime similar to harmful substances like alcohol and tobacco a solution?
For the latest news on cannabis reform worldwide click here
International Drug Policy Consortium
The legal status of cannabis for personal use is one of the most controversial policy issues in the European Union. Although cannabis is a classified narcotic drug placed under control by the United Nations and by all EU Member States, the measures adopted to control it at national level vary considerably, as shown in the table, click here to access the information country by country.READ MORE...
Previous research at York showed that regulating cannabis use could result in more effective strategies aimed at helping drug users to access the right support and guidanceUniversity of York (UK)
Thursday, April 20, 2017
Scientists at the University of York have shown that the risk of developing psychosis, such as hallucinations, from cannabis use is small compared to the number of total users. The research, published in the journal, Addiction, also showed for the first time that there is sufficient evidence to demonstrate that for patients who already have schizophrenia, cannabis makes their symptoms worse. In order to prevent just one case of psychosis, more than 20,000 people would have to stop using cannabis, as shown by a previous study led by the University of Bristol.
An overviewBrendan HughesEMCDDA
At a time of increased debate on the laws controlling the use of cannabis in the European Union, this report answers some of the questions most often asked about cannabis legislation. Using a question and answer format, basic definitions and the obligations of countries under international law are set out in a section on ‘What is cannabis and what are countries’ obligations to control it?‘ Two following sections examine the links and disparities between the content of the laws and their guidelines on the one hand and the actual implementation of the laws on the other. The final question and answer section considers whether changes in law have affected cannabis use and how much public support for legal change exists, as it looks at the future direction of cannabis legislation in Europe.
Download the report (PDF)READ MORE...
Reduction, containment or acceptanceTom BlickmanDrug Policy Briefing Nr. 49
This policy briefing discusses whether or not the aim of reducing cannabis cultivation is realistic or beneficial for Morocco, what it would actually mean for the major production area the Rif – one of the poorest, most densely populated and environmentally fragile regions in the country – and what that could imply for meaningful sustainable development. The briefing will give some historical background, discuss developments in the cannabis market, and highlight environmental and social consequences as well as the recent debate about regulation in Morocco and about European policies.
Download the briefing (PDF)READ MORE...
Pola konsumsi, produksi, dan kebijakanDania Putri & Tom BlickmanDrug Policy Briefing Nr. 44
Penggunaan ganja tidak pernah menimbulkan masalah besar di Indonesia, namun kebijakan prohibitionist (pelarangan) tetap diberlakukan sampai sekarang. Meskipun prevalensi konsumsi ganja cukup tinggi, diskusi lokal atau nasional terkait kebijakan ganja jarang sekali dilakukan. Hal ini juga diperburuk oleh sikap anti-narkotika serta kegagalan institusi publik dalam merancang dan menerapkan kebijakan yang berbasis ilmiah. Karena perundang-undangan anti-narkotika yang berlaku saat ini, terdapat banyak hambatan dalam proses penelitian tentang ganja, baik dari segi medis maupun antropologi.READ MORE...
A comparative analysis of legal and self-regulatory practices in Spain, Belgium and UruguayTom Decorte, Mafalda Pardal, Rosario Queirolo, Maria Fernanda Boidi, Constanza Sánchez Avilés, Òscar Parés FranqueroInternational Journal of Drug Policy
Volume 43, Pages 44–56
May 2017 (Published online: February 10, 2017)
Cannabis Social Clubs (CSCs) are a model of non-profit production and distribution of cannabis among a closed circuit of adult cannabis users. CSCs are now operating in several countries around the world, albeit under very different legal regimes and in different socio-political contexts. In this paper we describe and compare the legal framework and the self-regulatory practices of Cannabis Social Clubs in three countries (Spain, Belgium, and Uruguay). The objective of our comparative analysis is to investigate how CSCs operate in each of these countries. To foster discussions about how one might regulate CSCs to promote public health objectives, we conclude this paper with a discussion on the balance between adequate governmental control and self-regulatory competences of CSCs.
Download the article (PDF)READ MORE...
The year has seen another mountain of marijuana research, and there's a lot of good newsAlternet (US)
Thursday, December 29, 2016
While no psychoactive substance is completely harmless, modern science continues to prove that cannabis is one of the safer and more effective therapeutic agents available. Here’s a look back at some of the most significant marijuana-centric studies published over the past year. The cumulative use of cannabis by adolescents has no ill effect on intelligence, according to longitudinal data published in January in the Proceedings of the National Academy of Sciences. Investigators concluded: "In the largest longitudinal examination of marijuana use and IQ change, ... we find little evidence to suggest that adolescent marijuana use has a direct effect on intellectual decline.”
Assessing Uruguay's historic cannabis initiativeGeoff RamseyWashington Office on Latin America (WOLA)
After close to three years, the final element of Uruguay’s historic cannabis law is set to be implemented in the coming weeks, as commercial sales are expected to begin soon. While advancements have been slow and deliberate, Uruguay is not alone in taking such a cautious approach. The U.S. state of Maryland, for instance, approved a medical cannabis program in 2013, but a series of careful adjustments has postponed sales until 2017.
Download the report (PDF)READ MORE...
Recent developments in cannabis regulation
Cannabis is the most widely produced and consumed illicit substance globally. A significant number of states have long engaged in soft defection from the UN drug control regime in relation to tolerant policies on the personal possession, cultivation and use of cannabis. Recently, there has been growing debate within political circles on the benefits of regulated cannabis markets. This has been driven by a number of factors, including the continuing illegality of supply, the associated and often violent involvement of criminal elements and the use of finite criminal justice resources. In this section you will find an overview of our most recent blogs on the issue.
Latest: Silver linings: U.S. State votes to legalize cannabis boost reform opportunities in the Americas, John Walsh, November 10, 2016READ MORE...
Pre-Review ReportH. Valerie Curran, Philip Wiffen, David J. Nutt & Willem ScholtenDrugScience
The scheduling under the Single Convention on Narcotic Drugs assumes a scientific justification. However, cannabis and cannabis resin have never been evaluated by the World Health Organisation (WHO) since it was mandated the review of psychoactive substances in 1948. The last evaluation for the international substance control conventions were therefore when the League of Nations evaluated them in 1924 and 1935. In 80 years since that decision, both the social context of cannabis use and the science of drug dependence have dramatically changed.
Download the report (PDF)READ MORE...
Page 1 of 11